Mastrapasqua Asset Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.43M | Sell |
24,696
-150
| -0.6% | -$9.19K | 0.17% | 99 |
|
|
2023
Q2 | $1.59M | Sell |
24,846
-946
| -4% | -$63.4K | 0.18% | 93 |
|
|
2023
Q1 | $1.79M | Buy |
25,792
+125
| +0.5% | +$8.82K | 0.22% | 85 |
|
|
2022
Q4 | $1.85M | Buy |
25,667
+2,608
| +11% | +$197K | 0.24% | 84 |
|
|
2022
Q3 | $1.64M | Buy |
23,059
+1,600
| +7% | +$116K | 0.24% | 86 |
|
|
2022
Q2 | $1.65M | Buy |
21,459
+525
| +3% | +$40K | 0.23% | 86 |
|
|
2022
Q1 | $1.53M | Sell |
20,934
-3,590
| -15% | -$241K | 0.17% | 102 |
|
|
2021
Q4 | $1.53M | Buy |
24,524
+515
| +2% | +$30.2K | 0.15% | 101 |
|
|
2021
Q3 | $1.42M | Sell |
24,009
-2,620
| -10% | -$173K | 0.16% | 107 |
|
|
2021
Q2 | $1.78M | Buy |
26,629
+2,205
| +9% | +$144K | 0.19% | 95 |
|
|
2021
Q1 | $1.54M | Buy |
24,424
+4,820
| +25% | +$300K | 0.18% | 97 |
|
|
2020
Q4 | $1.22M | Sell |
19,604
-4,475
| -19% | -$275K | 0.16% | 100 |
|
|
2020
Q3 | $1.45M | Buy |
24,079
+4,224
| +21% | +$254K | 0.2% | 91 |
|
|
2020
Q2 | $1.17M | Buy |
19,855
+2,985
| +18% | +$179K | 0.18% | 93 |
|
|
2020
Q1 | $940K | Buy |
16,870
+1,005
| +6% | +$61.4K | 0.18% | 92 |
|
|
2019
Q4 | $1.02M | Sell |
15,865
-270
| -2% | -$15.5K | 0.17% | 100 |
|
|
2019
Q3 | $818K | Sell |
16,135
-815
| -5% | -$38.3K | 0.15% | 101 |
|
|
2019
Q2 | $769K | Buy |
16,950
+950
| +6% | +$44.3K | 0.15% | 104 |
|
|
2019
Q1 | $763K | Buy |
16,000
+2,760
| +21% | +$137K | 0.15% | 108 |
|
|
2018
Q4 | $688K | Sell |
13,240
-1,840
| -12% | -$98.9K | 0.15% | 108 |
|
|
2018
Q3 | $936K | Sell |
15,080
-1,015
| -6% | -$60.2K | 0.18% | 98 |
|
|
2018
Q2 | $891K | Sell |
16,095
-175
| -1% | -$9.45K | 0.18% | 97 |
|
|
2018
Q1 | $1.03M | Sell |
16,270
-365
| -2% | -$23.5K | 0.21% | 92 |
|
|
2017
Q4 | $1.02M | Buy |
16,635
+690
| +4% | +$43.2K | 0.21% | 93 |
|
|
2017
Q3 | $1.02M | Sell |
15,945
-505
| -3% | -$29.5K | 0.21% | 91 |
|
|
2017
Q2 | $917K | Sell |
16,450
-910
| -5% | -$49.5K | 0.2% | 95 |
|
|
2017
Q1 | $944K | Buy |
17,360
+4,250
| +32% | +$233K | 0.21% | 90 |
|
|
2016
Q4 | $766K | Sell |
13,110
-410
| -3% | -$22.4K | 0.19% | 93 |
|
|
2016
Q3 | $729K | Buy |
13,520
+1,510
| +13% | +$97K | 0.18% | 92 |
|
|
2016
Q2 | $883K | Sell |
12,010
-1,335
| -10% | -$94.3K | 0.22% | 83 |
|
|
2016
Q1 | $852K | Buy |
13,345
+3,560
| +36% | +$225K | 0.2% | 87 |
|
|
2015
Q4 | $673K | Sell |
9,785
-3,740
| -28% | -$247K | 0.17% | 97 |
|
|
2015
Q3 | $801K | Buy |
13,525
+335
| +3% | +$21.3K | 0.21% | 88 |
|
|
2015
Q2 | $878K | Buy |
+13,190
| New | +$869K | 0.21% | 83 |
|
|
2015
Q1 | – | Sell |
-13,035
| Closed | -$769K | – | 52 |
|
|
2014
Q4 | $769K | Buy |
+13,035
| New | +$735K | 0.19% | 91 |
|
|
2014
Q2 | $588K | Sell |
12,120
-112,998
| -90% | -$5.57M | 0.14% | 108 |
|
|
2014
Q1 | $6.5M | Buy |
125,118
+15,647
| +14% | +$833K | 1.53% | 25 |
|
|
2013
Q4 | $5.82M | Sell |
109,471
-524
| -0.5% | -$26.7K | 1.32% | 30 |
|
|
2013
Q3 | $5.09M | Buy |
109,995
+98,865
| +888% | +$4.34M | 1.25% | 33 |
|
|
2013
Q2 | $497K | Buy |
+11,130
| New | +$483K | 0.13% | 107 |
|
Other funds holding BMY
Mastrapasqua Asset Management's BMY Position: Q3 2023 in Review
Mastrapasqua Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 0.6% in Q3 2023, selling an estimated $9.19K and leaving 24,696 shares worth $1.43M. The position accounts for 0.17% of the portfolio, ranked #99.
Mastrapasqua Asset Management first reported a position in BMY in Q2 2013 and has held it in 40 quarters since. The position peaked at $6.5M in Q1 2014. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.
- Mastrapasqua Asset Management held 24,696 shares of Bristol-Myers Squibb worth $1.43M as of Q3 2023.
- Mastrapasqua Asset Management sold 150 Bristol-Myers Squibb shares in Q3 2023, an estimated $9.19K.
- Bristol-Myers Squibb made up 0.17% of Mastrapasqua Asset Management's portfolio in Q3 2023, its #99 holding.
- Mastrapasqua Asset Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 40 quarters since.
- Mastrapasqua Asset Management's Bristol-Myers Squibb position peaked at $6.5M in Q1 2014.
- 2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.
Based on Mastrapasqua Asset Management's 13F filing for Q3 2023, filed 25 Oct 2023.